Summary
A total of 17 patients with angiographically proven coronary artery disease and at least one stenosis blocking ≥ 70% of the left anterior descending or circumflex artery were included in a double-blind, randomized study. They received either 5 mg carvedilol or 6 mg propranolol intravenously. Heart rate, aortic pressure, mean coronary sinus pressure and coronary flow (thermodilution) were measured and coronary resistance and the rate-pressure product were calculated before and 25 min after injection. Carvedilol significantly (P < 0.05) lowered the heart rate (mean, 76 to 69 beats/min), aortic pressure (mean, 153/80–135/72 mmHg), rate-pressure product (mean, 117–93 mmHg/min), and coronary flow (mean, 114–94 ml/min). Coronary resistance (mean, 0.97–1.07 mmHg × min/ml) and coronary flow related to the rate-pressure product (mean, 1.0–1.02 ml/mm Hg) showed no significant change after carvedilol treatment. Propranolol lowered the heart rate (mean, 76–64/min;P < 0.05) and rate-pressure product (mean, 109–96 mm. Hg/min; not significant). Aortic pressure (mean, 145/72–147/74 mmHg), coronary flow (mean 109–101 ml/min), coronary resistance (mean, 1.1–1.2 mmHg × min/ml), and coronary flow related to the rate-pressure product (mean,1.12–1.19 ml/mmHg) showed no significant change after propranolol administration. Following single application, carvedilol lowered the rate-pressure product more markedly than did propranolol on account of its acute blood-pressure-lowering effect. No differences in the hemodynamic effects of carvedilol and propranolol were found. Neither drug seems to influence the adaption of coronary flow to myocardial oxygen demand.
Similar content being viewed by others
References
Ganz W, Tamura K, Marcus HS, Donoso R, Yoshiba S, Swan HJC (1971) Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 44: 181–195
Hellige G (1981) Koronardurchblutung. In: Krayenbühl HP, Kübler W (eds) Kardiologie in Klinik and Praxis, vol 1. Thieme, Stuttgart New York, pp 8.1–8.12
Knabb RM, Ely SW, Bacchus AN, Rubio R, Berne RM (1983) Consistent parallel relationships among myocardial oxygen consumption, coronary blood flow, and pericardial infusate adenosine concentration with various interventions and β-blockade in the dog. Cite Res 53: 33–41
Miller WL, Belardinelle L, Bacchus AN, Foley DA, Rubio R, Berne RM (1979) Canine myocardial adenosine and lactate production, oxygen consumption, and coronary blood flow during stellate ganglion stimulation. Circ Res 45: 708–718
Mueller HS, Ayers SM, Religa A, Evans RG (1974) Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygen and hemodynamics. Circulation 49: 1078–1087
Nayler WG, McInnes I, Swann JB, Carson V, Lowe TE (1967) Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields. Am Heart J 73: 207–216
Sponer G, Bartsch W, Strein K, Müller-Beckmann B, Böhm E (1987) Pharmacological profile of carvedilol as a β-blocking agent with vasodilating and hypotensive properties. J Cardiovasc Pharmacol 9: 317–327
Wendt Th, van der Does R, Schräder R, Landgraf H, Kober G (1987) Acute hemodynamic effects of the vasodilating and betablocking agent carvedilol in comparison to propranolol. J Cardiovasc Pharmacol 10 [Suppl 11]: 147–150
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sievert, H., Frey, G., Schräder, R. et al. Influence of carvedilol and propranolol on coronary blood flow. Eur J Clin Pharmacol 38 (Suppl 2), S122–S124 (1990). https://doi.org/10.1007/BF01409480
Issue Date:
DOI: https://doi.org/10.1007/BF01409480